Safety and efficacy of elagolix (with and without add-back therapy) for the treatment of heavy menstrual bleeding associated with uterine leiomyomas: a systematic review and meta-analysis

被引：0
|
作者：
Mustafa Ali
Aruna Kumari Hira
Haris Jawaid
Faiza Zakaria
Zehra Somjee
机构：
[1] Dow University of Health Sciences,Dow Medical College
[2] Dow University of Health Sciences,Obstetrics & Gynaecology Unit I
来源：
Middle East Fertility Society Journal | / 26卷
关键词：
Elagolix; Uterine leiomyoma; Heavy menstrual bleeding; Meta-analysis; Add-back therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Safety and efficacy of elagolix (with and without add-back therapy) for the treatment of heavy menstrual bleeding associated with uterine leiomyomas: a systematic review and meta-analysis
    Ali, Mustafa
    Hira, Aruna Kumari
    Jawaid, Haris
    Zakaria, Faiza
    Somjee, Zehra
    MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2021, 26 (01)
  • [2] Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas A Randomized Controlled Trial
    Carr, Bruce R.
    Stewart, Elizabeth A.
    Archer, David F.
    Al-Hendy, Ayman
    Bradley, Linda
    Watts, Nelson B.
    Diamond, Michael P.
    Gao, Jingjing
    Owens, Charlotte D.
    Chwalisz, Kristof
    Duan, W. Rachel
    Soliman, Ahmed M.
    Dufek, Matthew B.
    Simon, James A.
    OBSTETRICS AND GYNECOLOGY, 2018, 132 (05): : 1252 - 1264
  • [3] A systematic review and meta-analysis comparing the use of elagolix therapy alone or in combination with add-back therapy to treat women with uterine fibroid associated heavy menstrual bleeding
    Wang, Xianying
    Li, Jingxin
    Liu, Yang
    Zheng, Yingying
    Wang, Xiaoli
    Liu, Guoqiang
    GLAND SURGERY, 2025, 14 (01)
  • [4] Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids
    Al-Hendy, Ayman
    Bradley, Linda
    Owens, Charlotte D.
    Wang, Hui
    Barnhart, Kurt T.
    Feinberg, Eve
    Schlaff, William D.
    Puscheck, Elizabeth E.
    Wang, Alice
    Gillispie, Veronica
    Hurtado, Sandra
    Muneyyirci-Delale, Ozgul
    Archer, David F.
    Carr, Bruce R.
    Simon, James A.
    Stewart, Elizabeth A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (01)
  • [5] Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis
    Juliawati Muhammad
    Yusnita Yusof
    Imran Ahmad
    Mohd Noor Norhayati
    BMC Women's Health, 22
  • [6] Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis
    Muhammad, Juliawati
    Yusof, Yusnita
    Ahmad, Imran
    Norhayati, Mohd Noor
    BMC WOMENS HEALTH, 2022, 22 (01)
  • [7] Elagolix Alone and With Add-Back Decreases Heavy Menstrual Bleeding in Women With Uterine Fibroids
    Stewart, Elizabeth
    Owens, Charlotte
    Duan, W. Rachel
    Gao, Jingjing
    Chwalisz, Kristof
    Simon, James A.
    OBSTETRICS AND GYNECOLOGY, 2017, 129 : 87S - 88S
  • [8] Bone Mineral Density After 48 Months of Elagolix plus Add-Back Therapy in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids.
    Schnell, Vicki L.
    Simon, James
    Brown, Eric
    Bredeson, Liesl
    Thomas, James
    Chan, Anna
    Snabes, Michael C.
    REPRODUCTIVE SCIENCES, 2024, 31 : 109A - 109A
  • [9] Elagolix With Add-Back Rapidly Improves Nonbleeding Symptoms in Individuals With Fibroid-Associated Heavy Menstrual Bleeding
    Simon, James
    Jewell, Susan
    Li, Moming
    Ng, Juki
    Pinsky, Brett
    OBSTETRICS AND GYNECOLOGY, 2023, 141 : 13S - 13S
  • [10] Clinical efficacy of add-back therapy in treatment of endometriosis: a meta-analysis
    Wu, Debin
    Hu, Min
    Hong, Li
    Hong, Shasha
    Ding, Wenjuan
    Min, Jie
    Fang, Gui
    Guo, Wenjun
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (03) : 513 - 523
12345